Remove Benchmarking Remove Economics Remove Pharmaceutical Remove Valuation
article thumbnail

Transcript: David Conrod – The Big Picture

CFO News Room

So, you have the headquarters of a big pharmaceutical company, and they — they’re looking to raise some cash, maybe not a pharmaceutical company, but some other business. economics, correct. RITHOLTZ: Oh, not the control, just the economics. capital problem helps improve our economic sharing …. Is that right?

article thumbnail

Transcript: Richard Bernstein

Barry Ritholtz

You get a BA in Economics from Hamilton College. So what we did was we figured out the economic rationale, the macroeconomic influences about why growth and value work at any point in time. Everybody wants to sell a company when they get a good valuation. So we do a lot of valuation work. You get an MBA from NYU.

article thumbnail

Transcript: Joel Tillinghast, Fidelity

Barry Ritholtz

He has absolutely crushed his benchmark over that period. He’s crushed the Russell 2000, whatever benchmark you want to talk about. You’re 34th, you’re retiring after 34 years and you trounce what’s really the more appropriate benchmark, I would assume the Russell 2000. a year since 1989. Much better.